News
Simponi and Simponi Aria (golimumab) can cause mild to serious side effects. A more common side effect includes upper respiratory infection. If side effects from the drug become difficult to ...
Simponi is given by subcutaneous injection using the available prefilled syringe or SmartJect auto-injector. (You may be able to self-inject the drug at home after your doctor shows you how.) ...
Alvotech is the first company to announce positive topline results of a clinical trial using a proposed biosimilar to Simponi and Simponi Aria and is one of only two companies known to have ...
After 3 to 6 months, your symptoms may improve even more. Some TNF inhibitors, including Cimzia, Humira, Enbrel, Erelzi, and Simponi, are given as shots under the skin. You'll get your first one ...
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab) Alvotech Mon, Jan 27, 2025, 6:00 AM ...
In April 2024, Alvotech announced positive top-line results from a confirmatory clinical study comparing efficacy, safety, and immunogenicity between AVT05 and Simponi® in patients with moderate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results